Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ho-Sup Lee

Showing results (61-70 of 137) with videos related to

Pageof 14
Sort By:
Scientific Reports|February 13, 2023
Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in KoreaDa Jung Kim, Seri Jeong, Seom Gim Kong, et al.
Experimental Hematology|September 2, 2015
Induction chemotherapy followed by up-front autologous stem cell transplantation may have a survival benefit in high-risk diffuse large B-cell lymphoma patientsHo-Jin Shin, Dok Hyun Yoon, Ho Sup Lee, et al.
Plos One|July 30, 2020
The risk factors associated with treatment-related mortality in 16,073 kidney transplantation-A nationwide cohort studyHyunji Choi, Woonhyoung Lee, Ho Sup Lee, et al.
International Journal of Hematology|June 29, 2019
The Glasgow Prognostic Score is a significant predictor of peripheral T-cell lymphoma (PTCL) treated with CHOP-based chemotherapy and comparable with PTCL prognostic scoresSeok Jae Huh, Sung Yong Oh, Suee Lee, et al.
British Journal of Haematology|June 10, 2019
Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndromeHawk Kim, Je-Hwan Lee, Won-Sik Lee, et al.
Annals of Hematology|December 4, 2014
Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantationSeong Hyun Jeong, Joon Ho Moon, Jin Seok Kim, et al.
Acta Haematologica|July 8, 2010
Clinical value of absolute lymphocyte counts before bortezomib-dexamethasone therapy in relapsed multiple myeloma patientsMoo-Kon Song, Joo-Seop Chung, Young-Don Joo, et al.
Cell Transplantation|July 21, 2022
Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHDDong Won Baek, Hee Jeong Cho, Ju-Hyung Kim, et al.
The Korean Journal of Hematology|January 22, 2011
Incidence and clinical characteristics of clonal cytogenetic abnormalities of acquired aplastic anemia in adultsJi Hyun Lee, Kyung A Kwon, Suee Lee, et al.
The Korean Journal of Internal Medicine|September 11, 2015
The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in KoreaCheolsu Kim, Ho Sup Lee, Chang-Ki Min, et al.
Pageof 14

Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
Scientific Reports|February 13, 2023
Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in KoreaDa Jung Kim, Seri Jeong, Seom Gim Kong, et al.
Experimental Hematology|September 2, 2015
Induction chemotherapy followed by up-front autologous stem cell transplantation may have a survival benefit in high-risk diffuse large B-cell lymphoma patientsHo-Jin Shin, Dok Hyun Yoon, Ho Sup Lee, et al.
Plos One|July 30, 2020
The risk factors associated with treatment-related mortality in 16,073 kidney transplantation-A nationwide cohort studyHyunji Choi, Woonhyoung Lee, Ho Sup Lee, et al.
International Journal of Hematology|June 29, 2019
The Glasgow Prognostic Score is a significant predictor of peripheral T-cell lymphoma (PTCL) treated with CHOP-based chemotherapy and comparable with PTCL prognostic scoresSeok Jae Huh, Sung Yong Oh, Suee Lee, et al.
British Journal of Haematology|June 10, 2019
Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndromeHawk Kim, Je-Hwan Lee, Won-Sik Lee, et al.
Annals of Hematology|December 4, 2014
Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantationSeong Hyun Jeong, Joon Ho Moon, Jin Seok Kim, et al.
Acta Haematologica|July 8, 2010
Clinical value of absolute lymphocyte counts before bortezomib-dexamethasone therapy in relapsed multiple myeloma patientsMoo-Kon Song, Joo-Seop Chung, Young-Don Joo, et al.
Cell Transplantation|July 21, 2022
Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHDDong Won Baek, Hee Jeong Cho, Ju-Hyung Kim, et al.
The Korean Journal of Hematology|January 22, 2011
Incidence and clinical characteristics of clonal cytogenetic abnormalities of acquired aplastic anemia in adultsJi Hyun Lee, Kyung A Kwon, Suee Lee, et al.
The Korean Journal of Internal Medicine|September 11, 2015
The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in KoreaCheolsu Kim, Ho Sup Lee, Chang-Ki Min, et al.
Pageof 14